Accession |
641 |
Title |
Integrative proteomic and gene expression analysis identify potential biomarkers for adjuvant trastuzumab resistance: analysis from the Fin-her phase III randomized trial |
Summary |
By integrating mRNA and protein expression data from Reverse-Phase Protein Array Analysis (RPPA) in HER2-positive BC, we developed gene expression metagenes that reflect pathway activation levels. |
Journal |
Oncotarget |
Publish date |
September, 2015 |
Corresponding Author |
Christos Sotiriou |
E-mail |
christos.sotiriou@bordet.be |
Array Type |
Reverse phase protein array |
Species |
Homo sapiens |
Raw data link |
No relevant experiment link!
|
Link to PubMed |
PubMed ID:26358523
|